Ampersand reports AMP-410 data at AACR IO

Compositions and methods for targeted delivery of therapeutic agents

Compositions for facilitating membrane fusion and uses thereof

Methods and compositions for modulating a genome

Scientist I - Bioconjugate Lead, Protein Sciences

Ampersand Biomedicines is a Flagship Pioneering company focused on transforming patients' lives with programmed medicines. The role involves contributing to the discovery and development of AND-Body™ Therapeutics by creating and analyzing new antibody modalities for targeted biologic therapies.

Vice President, Biologics Division

Pharmaceutical manufacturer to close Mass. facility, lay off 81

Curia Releases 2024 Environmental, Social and Governance...

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

Curia Invests $4 Million to Enhance Sterile API Manufacturing

0.3333333432674408

Research Scientist I; Protein Science

Curia is a global contract development and manufacturing organization with over 30 years of experience partnering with pharmaceutical and biotech companies. The Research Scientist I is responsible for protein purification and characterization, as well as conducting laboratory operations in a safe manner.

Curia is a global contract development and manufacturing organization dedicated to advancing therapies that save lives. The Research Scientist I role focuses on protein purification, characterization, and crystallography, with responsibilities including conducting experiments and maintaining accurate records.

Senior Vice President, Corporate Affairs

Chief Legal Officer

Chutes & Ladders—Sanofi's stunning CEO switch

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs

Top biotech deals in November 2025

Scientist I, Protein Science

Voyager Therapeutics is a biotechnology company focused on curing neurological diseases through human genetics. They are seeking a Scientist I in Protein Science to purify, characterize, and deliver high-quality proteins to support the development of novel biotherapeutics, collaborating with various teams in the process.

Chief Operating Officer

Consulting CMO

MDX-2003 exerts potent activity in preclinical B-cell malignancies

Top biotech deals in October 2025

OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Regeneron and ModeX Therapeutics Form Multi-Billion-Dolla...

Temporary Scientist I, Protein Science

ModeX Therapeutics Inc is a rapidly growing biotech company focused on developing cutting-edge biotherapeutics. They are seeking a highly skilled biochemist to join their Protein Science group for a 12-month period to design, produce, and characterize novel therapeutic antibodies as part of a multidisciplinary team.

Temporary Scientist I, Protein Science (12-Month Position)

Founder and CEO

Corteva earnings on deck as corn acres debate takes center stage

AgriFood Signals: BinSentry bags another $25m, Lloyds backs regen ag, Zepto IPO

Corteva, Hexagon Bio Form Joint Venture to Develop Crop Protection Products

Corteva, Hexagon Bio enter multi-million-dollar crop protection joint venture

Scientist I/II, Protein Science

Hexagon Bio is a biotechnology company focused on developing next-generation ADCs for cancer treatment. They are seeking a highly motivated Scientist I/II to join their Protein Science team, where the role involves antibody-drug conjugation, purification, and analytical characterization to support the ADC pipeline.

Managing Partner, TCG Labs  |  Co-Founder and Chief Executive Officer, Soleil 

VP, Discovery Research and Co-Founder

TCG raises $400 million to spur single-asset biotech model

Financings for July 25, 2025

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer

0.6666666865348816

Associate Scientist / Scientist I, Protein Sciences, Biophysical Assays, SPR

TCG Labs-Soleil is building a team of scientists driven to push the boundaries of therapeutic discovery. They are seeking a motivated Associate Scientist/Scientist I to join their Protein Sciences team and contribute to the advancement of a diverse biologics pipeline through hands-on design and execution of assays.

ModeX Therapeutics Inc is a rapidly growing biotech company focused on developing cutting-edge biotherapeutics. They are seeking an experienced biochemist to join their Protein Science group, where the individual will be responsible for the design, production, and functional characterization of therapeutic proteins and multispecific antibodies.

Chief Executive Officer

SVP, General Counsel & Secretary

Veranova Appoints Joe Torres-Ocasio as Senior Vice President, Chief Operating Officer

Chutes & Ladders—Novo Nordisk nominates CEO successor

Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides

Contract biomanufacturer Veranova to add jobs after moving HQ to Devens

0.1666666716337204

Sr Scientist, PRD Tech Transfer Bioconjugation

Veranova is a global leader in the development and manufacturing of complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. They are seeking a highly motivated and skilled bioconjugation scientist to lead the technology transfer of bioconjugate processes from development to manufacturing scale, ensuring compliance with industry standards.

FDA Dosage Optimization of Antibody-Drug Conjugates

Oak Ridge Institute for Science and Education is associated with the U.S. Food and Drug Administration (FDA) and is offering a research opportunity focused on dosage optimization of antibody-drug conjugates (ADCs). The role involves collecting and analyzing data related to ADC characteristics and dose selection, contributing to regulatory science and policy development in clinical pharmacology.

Chairman of the Board and Chief Executive Officer

Vice President and Chief Financial Officer

Low coefficient of thermal expansion alloys

High molybdenum duplex stainless steel

Articles fabricated from cold-worked and case-hardened essentially co-free …

Carpenter Technology announces Malloy to succeed Thene as CEO

Principal Metallurgist - Technology

Carpenter Technology Corporation is a leading producer and distributor of premium specialty alloys. The Principal Metallurgist – Technology will provide technical services, manage functional project teams, and support both internal and external customers in achieving company goals.

President

SheTech Interns Interview Amy Larson

1-800 Contacts Announces The Framery at 1-800 Contacts, A New Online Retailer For Affordable, High-Quality Eyewear

Settlement In 1-800 Contacts Gets Early OK

Court Rejects FTC Antitrust Case Against 1-800 Contacts

Optical Manufacturing Technician 2

SeekWell is the parent company of 1-800 Contacts, dedicated to making vision care more accessible. As an Optical Lab Technician 2, you will work hands-on in a state-of-the-art lab to craft high-quality eyewear, ensuring precision and quality in production.

Vice President Research And Development

Global Human Epidermal Growth Factor Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034

Global Immunostimulants Market Poised for Robust Growth, Expected to Surpass USD 225.03 Million by 2035

Cd28 binding antibodies and antigen binding fragments thereof

Tmprss2 binding antibodies and antigen binding fragments thereof

Biotechnician, Buffer

BioLegend is committed to providing researchers with high-quality reagents for life science research. The Biotechnician will be responsible for preparing buffers, performing production support activities, and collaborating with various teams to support buffer manufacturing and additional production tasks.

Scheduling Lead PHC/OPWDD

Thailand's Pride Health raises $300,000 to boost LGBTQ+ healthcare across Asia

SEA Digest: SG's Wiz.AI, Thailand's Pride Health raise funding

Scientist II - Bioconjugation and Delivery

Pride Health is seeking a Scientist II for an American biotechnology corporation in South San Francisco, CA. The Bioconjugation and Delivery group is responsible for the design and generation of new therapeutic modalities, and the role involves applying advanced bioconjugation techniques in drug development.

Scientist II  - Bioconjugation and Delivery

R&D Partners Research Scientist at Bristol Myers Squibb

Founder and Member of Board of Directors

Scientist II (Bioconjugations)

R&D Partners is a global functional service provider specializing in scientific, clinical research & engineering. They are seeking a talented early-in-career Scientist to join their Bioconjugation and Delivery group to advance therapeutic design through the application of advanced bioconjugation techniques.

Chief Financial Officer

Mosaic Biosciences Unveils New Website Highlighting Antibody Discovery Services and Protein Engineering Platforms

Mosaic Biosciences Appoints Jean Pierre Wery as Chief Executive Officer

AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone and Royalty-Free Access to AbTherx’s Premier Human Antibody Discovery Technology

Mosaic Biosciences Receives National Agri-Marketing Award

Sr. Associate Scientist (I/II), Protein Production

Mosaic Biosciences is a biotherapeutics drug discovery company that partners with biopharmaceutical companies to discover novel protein and antibody therapeutics. They are seeking a full-time Sr. Associate Scientist I or II to join their Protein Production team in Boulder, Colorado, where the successful candidate will execute and optimize protein expression and purification workflows while collaborating with a cross-functional scientific team.

Chief Executive Officer, CEO

Co-Founder

Samsung invests in US gene editing firm Arbor

Fierce 15: Where are they now?

Chiesi fertilizes Arbor's rare disease gene therapy efforts with $2B biobucks deal

Associate Director, Protein Engineering

Arbor Biotechnologies is a next-generation gene editing company advancing novel gene editing therapeutics. The Associate Director will lead the protein engineering team, maximizing the efficacy of genome editing tools and driving initiatives to improve enzyme activity and performance across diverse editing contexts.

Senior Vice President - Strategic Partnerships

Software Guidance & Assistance, Inc. is searching for a Scientist II - Bioconjugation and Delivery for a contract assignment with one of their premier Pharmaceutical clients. The role involves designing and generating therapeutic modalities and applying advanced bioconjugation techniques in drug development.

Executive Vice President and Chief Human Resources Officer

Executive Vice President and President, Merck Research Laboratories

Lipid Nanoparticles Market to Reach $3.1 Billion, Globally, by 2033 at 13.1% CAGR: Allied Market Research

AI-Powered Tempus Inks New Multi-Year Merck Deal

Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground

Merck advances Welireg into earlier-stage kidney cancer with Phase III win

Principal Scientist, Biologics Formulations

Merck is a leading pharmaceutical company seeking a Principal Scientist with expertise in biologics formulation development. The role focuses on the characterization, early formulation development, and developability assessment for various biologics modalities, while also mentoring junior scientists and collaborating with cross-functional teams.

Principal Scientist, Biologics Formulations (Discovery Pharmaceutical Sciences)

Member of the Board of Management of Bayer AG and CFO

VP, CGT Platform Implementation Lead

Bayer spies an end to a long legal battle

Bayer secures expanded FDA clearances for MRI contrast agent injector

In the $7.25 billion Roundup settlement, opting out comes at a price

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

Principal Scientist, Complex in Vitro Expert, CVRI

Bayer is a visionary company striving to solve the world's toughest challenges, and they are seeking a Principal Scientist to join their Cardiovascular-Renal In Vitro Research group. The role involves leading drug discovery programs, designing advanced cellular models, and collaborating with internal and external partners to enhance expertise in complex in vitro biology for cardiac and renal diseases.

Scientist I   Bioconjugate Lead, Protein Sciences

Scientist I Bioconjugate Lead, Protein Sciences in united states (1000+)